| Insideraktier | 14.861.253 shares |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Netto antal insidere, der køber (rang)
N/A
Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).
Procent af float købt af insidere (rangering)
N/A
Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.
Insiderhandelsdiagram
Codiak Biosciences Inc insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CDAK / Codiak Biosciences Inc. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CDAK / Codiak Biosciences Inc. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-30 | 2023-03-30 | 4 | Howze Yalonda | CDAK | Common Stock | D | 0,1955 | -1.628 | -0 | 7.458 | ||||
| 2023-03-30 | 2023-03-29 | 4 | Sathyanarayanan Sriram | CDAK | Common Stock | D | 0,1652 | -11.762 | -2 | 0 | ||||
| 2023-03-30 | 2023-03-28 | 4 | Konstantinov Konstantin | CDAK | Common Stock | D | 0,2000 | -1.932 | -0 | 0 | ||||
| 2023-03-30 | 2023-03-28 | 4 | Konstantinov Konstantin | CDAK | Common Stock | D | 0,2001 | -7.432 | -1 | 1.932 | ||||
| 2023-03-30 | 2023-03-29 | 4 | Barna Nicole | CDAK | Common Stock | D | 0,1660 | -1.932 | -0 | 4.849 | ||||
| 2023-03-30 | 2023-03-29 | 4 | Barna Nicole | CDAK | Common Stock | D | 0,1651 | -5.373 | -1 | 6.781 | ||||
| 2023-03-30 | 2023-03-28 | 4 | Bain Linda | CDAK | Common Stock | D | 0,1693 | -13.412 | -2 | 0 | ||||
| 2023-03-30 | 2023-03-28 | 4 | WILLIAMS DOUGLAS E | CDAK | Common Stock | D | 0,1800 | -41.667 | -8 | 7.655 | ||||
| 2023-02-21 | 2023-02-16 | 4 | MELAS KYRIAZI THEO | CDAK | Common Stock | D | 8.750 | 15.350 | ||||||
| 2023-02-21 | 2023-02-16 | 4 | Bernstein Karen | CDAK | Common Stock | I | 8.750 | 8.750 | ||||||
| 2023-02-21 | 2023-02-17 | 4 | Bain Linda | CDAK | Common Stock | D | 0,5922 | -2.570 | -2 | 13.412 | ||||
| 2023-02-21 | 2023-02-16 | 4 | Bain Linda | CDAK | Common Stock | D | 7.613 | 15.982 | ||||||
| 2023-02-21 | 2022-08-17 | 4 | Bain Linda | CDAK | Common Stock | D | 2,2129 | -2.364 | -5 | 8.369 | ||||
| 2023-02-21 | 2022-08-16 | 4 | Bain Linda | CDAK | Common Stock | D | 7.613 | 10.733 | ||||||
| 2023-02-21 | 2023-02-16 | 4 | GILLIS STEVEN | CDAK | Common Stock | D | 8.750 | 8.750 | ||||||
| 2023-02-21 | 2023-02-16 | 4 | Haddock Jason | CDAK | Common Stock | D | 8.750 | 8.750 | ||||||
| 2023-02-21 | 2023-02-16 | 4 | COONEY CHARLES L | CDAK | Common Stock | D | 8.750 | 8.750 | ||||||
| 2023-02-21 | 2023-02-17 | 4 | WILLIAMS DOUGLAS E | CDAK | Common Stock | D | 0,5922 | -7.681 | -5 | 49.322 | ||||
| 2023-02-21 | 2023-02-16 | 4 | WILLIAMS DOUGLAS E | CDAK | Common Stock | D | 22.969 | 57.003 | ||||||
| 2023-02-21 | 2022-08-17 | 4 | WILLIAMS DOUGLAS E | CDAK | Common Stock | D | 2,2130 | -7.112 | -16 | 34.034 | ||||
| 2023-02-21 | 2022-08-16 | 4 | WILLIAMS DOUGLAS E | CDAK | Common Stock | D | 22.969 | 41.146 | ||||||
| 2023-02-21 | 2023-02-17 | 4 | Konstantinov Konstantin | CDAK | Common Stock | D | 0,5922 | -1.391 | -1 | 7.432 | ||||
| 2023-02-21 | 2023-02-16 | 4 | Konstantinov Konstantin | CDAK | Common Stock | D | 4.200 | 8.823 | ||||||
| 2023-02-21 | 2022-08-17 | 4 | Konstantinov Konstantin | CDAK | Common Stock | D | 2,2129 | -1.308 | -3 | 4.623 | ||||
| 2023-02-21 | 2022-08-16 | 4 | Konstantinov Konstantin | CDAK | Common Stock | D | 4.200 | 5.931 | ||||||
| 2023-02-21 | 2023-02-17 | 4 | Barna Nicole | CDAK | Common Stock | D | 0,5924 | -1.274 | -1 | 12.154 | ||||
| 2023-02-21 | 2023-02-16 | 4 | Barna Nicole | CDAK | Common Stock | D | 3.150 | 13.428 | ||||||
| 2023-02-21 | 2022-08-17 | 4 | Barna Nicole | CDAK | Common Stock | D | 2,2124 | -984 | -2 | 10.278 | ||||
| 2023-02-21 | 2022-08-16 | 4 | Barna Nicole | CDAK | Common Stock | D | 3.150 | 11.262 | ||||||
| 2023-02-21 | 2023-02-17 | 4 | Howze Yalonda | CDAK | Common Stock | D | 0,5929 | -1.603 | -1 | 9.086 | ||||
| 2023-02-21 | 2023-02-16 | 4 | Howze Yalonda | CDAK | Common Stock | D | 4.856 | 10.689 | ||||||
| 2023-02-21 | 2022-08-17 | 4 | Howze Yalonda | CDAK | Common Stock | D | 2,2135 | -1.512 | -3 | 5.833 | ||||
| 2023-02-21 | 2022-08-16 | 4 | Howze Yalonda | CDAK | Common Stock | D | 4.857 | 7.345 | ||||||
| 2023-02-21 | 2023-02-17 | 4 | Sathyanarayanan Sriram | CDAK | Common Stock | D | 0,5922 | -2.407 | -1 | 11.762 | ||||
| 2023-02-21 | 2023-02-16 | 4 | Sathyanarayanan Sriram | CDAK | Common Stock | D | 7.350 | 14.169 | ||||||
| 2023-02-21 | 2022-08-17 | 4 | Sathyanarayanan Sriram | CDAK | Common Stock | D | 2,2123 | -2.283 | -5 | 6.819 | ||||
| 2023-02-21 | 2022-08-16 | 4 | Sathyanarayanan Sriram | CDAK | Common Stock | D | 7.350 | 9.102 | ||||||
| 2023-01-23 | 2023-01-20 | 4 | Barna Nicole | CDAK | Common Stock | D | 0,5750 | -836 | -0 | 8.112 | ||||
| 2023-01-23 | 2023-01-19 | 4 | Barna Nicole | CDAK | Common Stock | D | 2.167 | 8.948 | ||||||
| 2023-01-23 | 2023-01-20 | 4 | Howze Yalonda | CDAK | Common Stock | D | 0,5752 | -1.512 | -1 | 2.488 | ||||
| 2023-01-23 | 2023-01-19 | 4 | Howze Yalonda | CDAK | Common Stock | D | 4.000 | 4.000 | ||||||
| 2023-01-23 | 2023-01-20 | 4 | Sathyanarayanan Sriram | CDAK | Common Stock | D | 0,5751 | -1.082 | -1 | 1.752 | ||||
| 2023-01-23 | 2023-01-19 | 4 | Sathyanarayanan Sriram | CDAK | Common Stock | D | 2.834 | 2.834 | ||||||
| 2023-01-23 | 2023-01-20 | 4 | WILLIAMS DOUGLAS E | CDAK | Common Stock | D | 0,5750 | -5.075 | -3 | 18.177 | ||||
| 2023-01-23 | 2023-01-19 | 4 | WILLIAMS DOUGLAS E | CDAK | Common Stock | D | 13.667 | 23.252 | ||||||
| 2023-01-23 | 2023-01-20 | 4 | Konstantinov Konstantin | CDAK | Common Stock | D | 0,5752 | -1.069 | -1 | 1.731 | ||||
| 2023-01-23 | 2023-01-19 | 4 | Konstantinov Konstantin | CDAK | Common Stock | D | 2.800 | 2.800 | ||||||
| 2023-01-23 | 2023-01-20 | 4 | Bain Linda | CDAK | Common Stock | D | 0,5750 | -1.880 | -1 | 3.120 | ||||
| 2023-01-23 | 2023-01-19 | 4 | Bain Linda | CDAK | Common Stock | D | 5.000 | 5.000 | ||||||
| 2022-09-16 | 2022-09-15 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. | CDAK | Common Stock | I | 210.743 | 1.188.920 | ||||||
| 2022-09-16 | 2022-09-15 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. | CDAK | Common Stock | I | 722.590 | 1.865.767 | ||||||
| 2022-09-15 | 2022-09-13 | 4 | GILLIS STEVEN See footnotes | CDAK | Common Stock | I | 5.000.000 | 7.503.903 | ||||||
| 2022-09-15 | 2022-09-13 | 4 | ARCH Venture Fund VIII, L.P. See footnotes | CDAK | Common Sotck | I | 1,5000 | 5.000.000 | 7.500 | 8.854.098 | ||||
| 2022-05-04 | 2022-05-02 | 4 | Mauro David J | CDAK | Restricted Stock Units | D | 20.000 | 20.000 | ||||||
| 2022-05-04 | 2022-05-02 | 4 | Mauro David J | CDAK | Stock Option (Right to Buy) | D | 3,26 | 200.000 | 200.000 | |||||
| 2022-02-18 | 2022-02-16 | 4 | MELAS KYRIAZI THEO | CDAK | Restricted Stock Units | D | 8.750 | 8.750 | ||||||
| 2022-02-18 | 2022-02-16 | 4 | WILLIAMS DOUGLAS E | CDAK | Restricted Stock Units | D | 91.875 | 91.875 | ||||||
| 2022-02-18 | 2022-02-16 | 4 | WILLIAMS DOUGLAS E | CDAK | Stock Option (Right to Buy) | D | 5,21 | 61.250 | 61.250 | |||||
| 2022-02-18 | 2022-02-16 | 4 | Barna Nicole | CDAK | Restricted Stock Units | D | 12.600 | 12.600 | ||||||
| 2022-02-18 | 2022-02-16 | 4 | Barna Nicole | CDAK | Stock Option (Right to Buy) | D | 5,21 | 8.400 | 8.400 | |||||
| 2022-02-18 | 2022-02-16 | 4 | Konstantinov Konstantin | CDAK | Restricted Stock Units | D | 16.800 | 16.800 | ||||||
| 2022-02-18 | 2022-02-16 | 4 | Konstantinov Konstantin | CDAK | Stock Option (Right to Buy) | D | 5,21 | 11.200 | 11.200 | |||||
| 2022-02-18 | 2022-02-16 | 4 | COONEY CHARLES L | CDAK | Restricted Stock Units | D | 8.750 | 8.750 | ||||||
| 2022-02-18 | 2022-02-16 | 4 | Sathyanarayanan Sriram | CDAK | Restricted Stock Units | D | 29.400 | 29.400 | ||||||
| 2022-02-18 | 2022-02-16 | 4 | Sathyanarayanan Sriram | CDAK | Stock Option (Right to Buy) | D | 5,21 | 19.600 | 19.600 | |||||
| 2022-02-18 | 2022-02-16 | 4 | Howze Yalonda | CDAK | Restricted Stock Units | D | 19.425 | 19.425 | ||||||
| 2022-02-18 | 2022-02-16 | 4 | Howze Yalonda | CDAK | Stock Option (Right to Buy) | D | 5,21 | 12.950 | 12.950 | |||||
| 2022-02-18 | 2022-02-16 | 4 | Brudnick Richard | CDAK | Restricted Stock Units | D | 16.275 | 16.275 | ||||||
| 2022-02-18 | 2022-02-16 | 4 | Brudnick Richard | CDAK | Stock Option (Right to Buy) | D | 5,21 | 10.850 | 10.850 | |||||
| 2022-02-18 | 2022-02-16 | 4 | Bain Linda | CDAK | Restricted Stock Units | D | 30.450 | 30.450 | ||||||
| 2022-02-18 | 2022-02-16 | 4 | Bain Linda | CDAK | Stock Option (Right to Buy) | D | 5,21 | 20.300 | 20.300 | |||||
| 2022-02-18 | 2022-02-16 | 4 | GILLIS STEVEN | CDAK | Restricted Stock Units | D | 8.750 | 8.750 | ||||||
| 2022-02-18 | 2022-02-16 | 4 | Bernstein Karen | CDAK | Restricted Stock Units | I | 8.750 | 8.750 | ||||||
| 2022-02-18 | 2022-02-16 | 4 | Haddock Jason | CDAK | Restricted Stock Units | D | 8.750 | 8.750 | ||||||
| 2022-02-07 | 2022-01-20 | 4 | Barna Nicole | CDAK | Common Stock | D | 7,3700 | 6.781 | 50 | 6.781 | ||||
| 2022-01-21 | 2022-01-19 | 4 | Brudnick Richard | CDAK | Restricted Stock Units | D | 8.400 | 8.400 | ||||||
| 2022-01-21 | 2022-01-19 | 4 | Brudnick Richard | CDAK | Stock Option (Right to Buy) | D | 7,21 | 41.000 | 41.000 | |||||
| 2022-01-21 | 2022-01-19 | 4 | Bain Linda | CDAK | Restricted Stock Units | D | 15.000 | 15.000 | ||||||
| 2022-01-21 | 2022-01-19 | 4 | Bain Linda | CDAK | Stock Option (Right to Buy) | D | 7,21 | 65.000 | 65.000 | |||||
| 2022-01-21 | 2022-01-19 | 4 | Sathyanarayanan Sriram | CDAK | Restricted Stock Units | D | 8.500 | 8.500 | ||||||
| 2022-01-21 | 2022-01-19 | 4 | Sathyanarayanan Sriram | CDAK | Stock Option (Right to Buy) | D | 7,21 | 45.000 | 45.000 | |||||
| 2022-01-21 | 2022-01-19 | 4 | Barna Nicole | CDAK | Restricted Stock Units | D | 6.500 | 6.500 | ||||||
| 2022-01-21 | 2022-01-19 | 4 | Barna Nicole | CDAK | Stock Option (Right to Buy) | D | 7,21 | 29.000 | 29.000 | |||||
| 2022-01-21 | 2022-01-19 | 4 | Konstantinov Konstantin | CDAK | Restricted Stock Units | D | 8.400 | 8.400 | ||||||
| 2022-01-21 | 2022-01-19 | 4 | Konstantinov Konstantin | CDAK | Stock Option (Right to Buy) | D | 7,21 | 42.000 | 42.000 | |||||
| 2022-01-21 | 2022-01-19 | 4 | WILLIAMS DOUGLAS E | CDAK | Restricted Stock Units | D | 41.000 | 41.000 | ||||||
| 2022-01-21 | 2022-01-19 | 4 | WILLIAMS DOUGLAS E | CDAK | Stock Option (Right to Buy) | D | 7,21 | 200.000 | 200.000 | |||||
| 2022-01-21 | 2022-01-19 | 4 | Howze Yalonda | CDAK | Restricted Stock Units | D | 12.000 | 12.000 | ||||||
| 2022-01-21 | 2022-01-19 | 4 | Howze Yalonda | CDAK | Stock Option (Right to Buy) | D | 7,21 | 52.000 | 52.000 | |||||
| 2021-09-28 | 2021-06-08 | 4 | Konstantinov Konstantin | CDAK | Stock Option (Right to Buy) | D | 3,29 | 7.276 | 92.978 | |||||
| 2021-09-28 | 2021-06-08 | 4 | Konstantinov Konstantin | CDAK | Common Stock | D | 26,0415 | -1.004 | -26 | 0 | ||||
| 2021-09-28 | 2021-06-08 | 4 | Konstantinov Konstantin | CDAK | Common Stock | D | 25,5310 | -6.272 | -160 | 1.004 | ||||
| 2021-09-28 | 2021-06-08 | 4 | Konstantinov Konstantin | CDAK | Common Stock | D | 3,2900 | 7.276 | 24 | 7.276 | ||||
| 2021-09-28 | 2021-06-08 | 4 | Sorensen Benny | CDAK | Stock Option (Right to Buy) | D | 3,29 | 8.533 | 87.411 | |||||
| 2021-09-28 | 2021-06-08 | 4 | Sorensen Benny | CDAK | Common Stock | D | 26,0608 | -1.640 | -43 | 0 | ||||
| 2021-09-28 | 2021-06-08 | 4 | Sorensen Benny | CDAK | Common Stock | D | 25,5732 | -6.893 | -176 | 1.640 | ||||
| 2021-09-28 | 2021-06-08 | 4 | Sorensen Benny | CDAK | Common Stock | D | 3,2900 | 8.533 | 28 | 8.533 | ||||
| 2021-09-28 | 2021-08-09 | 4 | Sathyanarayanan Sriram | CDAK | Stock Option (Right to Buy) | D | 3,29 | 1.300 | 48.666 | |||||
| 2021-09-28 | 2021-08-09 | 4 | Sathyanarayanan Sriram | CDAK | Common Stock | D | 21,7892 | -549 | -12 | 0 | ||||
| 2021-09-28 | 2021-08-09 | 4 | Sathyanarayanan Sriram | CDAK | Common Stock | D | 21,3083 | -751 | -16 | 549 | ||||
| 2021-09-28 | 2021-08-09 | 4 | Sathyanarayanan Sriram | CDAK | Common Stock | D | 3,2900 | 1.300 | 4 | 1.300 | ||||
| 2021-09-28 | 2021-08-06 | 4 | Sathyanarayanan Sriram | CDAK | Stock Option (Right to Buy) | D | 3,29 | 1.300 | 49.966 | |||||
| 2021-09-28 | 2021-08-06 | 4 | Sathyanarayanan Sriram | CDAK | Common Stock | D | 20,1585 | -1.300 | -26 | 0 | ||||
| 2021-09-28 | 2021-08-06 | 4 | Sathyanarayanan Sriram | CDAK | Common Stock | D | 3,2900 | 1.300 | 4 | 1.300 | ||||
| 2021-08-18 | 2021-08-16 | 4 | Pandite Arundathy N. | CDAK | Stock Option (Right to Buy) | D | 19,65 | 20.000 | 20.000 | |||||
| 2021-06-22 | 2021-06-18 | 4 | Bernstein Karen | CDAK | Stock Option (Right to Buy) | D | 24,13 | 10.000 | 10.000 | |||||
| 2021-06-22 | 2021-06-18 | 4 | COONEY CHARLES L | CDAK | Stock Option (Right to Buy) | D | 24,13 | 10.000 | 10.000 | |||||
| 2021-06-22 | 2021-06-18 | 4 | GILLIS STEVEN | CDAK | Stock Option (Right to Buy) | D | 24,13 | 10.000 | 10.000 | |||||
| 2021-06-22 | 2021-06-18 | 4 | MELAS KYRIAZI THEO | CDAK | Stock Option (Right to Buy) | D | 24,13 | 10.000 | 10.000 | |||||
| 2021-06-22 | 2021-06-18 | 4 | Haddock Jason | CDAK | Stock Option (Right to Buy) | D | 24,13 | 10.000 | 10.000 | |||||
| 2021-06-22 | 2021-06-09 | 4 | Sathyanarayanan Sriram | CDAK | Stock Option (Right to Buy) | D | 26,76 | 40.000 | 40.000 | |||||
| 2021-05-21 | 2021-05-17 | 4 | Eggimann Anne-Virginie | CDAK | Stock Option (Right to Buy) | D | 18,48 | 20.000 | 20.000 | |||||
| 2021-05-12 | 2021-05-10 | 4 | Wheler Jennifer J. | CDAK | Stock Option (Right to Buy) | D | 16,41 | 100.000 | 100.000 | |||||
| 2021-04-30 | 2020-10-13 | 4 | MELAS KYRIAZI THEO | CDAK | Common Stock | D | 15,0000 | 6.600 | 99 | 6.600 | ||||
| 2021-02-17 | 2021-02-17 | 4 | Morrison Briggs | CDAK | Common Stock | D | 21,0000 | 4.761 | 100 | 4.761 | ||||
| 2021-01-26 | 2021-01-22 | 4 | Verma Ajay | CDAK | Stock Option (Right to Buy) | D | 26,60 | 29.000 | 29.000 | |||||
| 2021-01-26 | 2021-01-22 | 4 | Bain Linda | CDAK | Stock Option (Right to Buy) | D | 26,60 | 58.000 | 58.000 | |||||
| 2021-01-26 | 2021-01-22 | 4 | Howze Yalonda | CDAK | Stock Option (Right to Buy) | D | 26,60 | 37.000 | 37.000 | |||||
| 2021-01-26 | 2021-01-22 | 4 | Konstantinov Konstantin | CDAK | Stock Option (Right to Buy) | D | 26,60 | 32.000 | 32.000 | |||||
| 2021-01-26 | 2021-01-22 | 4 | Brudnick Richard | CDAK | Stock Option (Right to Buy) | D | 26,60 | 31.000 | 31.000 | |||||
| 2021-01-26 | 2021-01-22 | 4 | Barna Nicole | CDAK | Stock Option (Right to Buy) | D | 26,60 | 24.000 | 24.000 | |||||
| 2021-01-26 | 2021-01-22 | 4 | Sorensen Benny | CDAK | Stock Option (Right to Buy) | D | 26,60 | 31.000 | 31.000 | |||||
| 2021-01-26 | 2021-01-22 | 4 | WILLIAMS DOUGLAS E | CDAK | Stock Option (Right to Buy) | D | 26,60 | -175.000 | 175.000 | |||||
| 2020-11-17 | 2020-11-13 | 4 | Haddock Jason | CDAK | Stock Option (Right to Buy) | D | 8,75 | 7.996 | 7.996 | |||||
| 2020-11-17 | 2020-11-13 | 4 | Howze Yalonda | CDAK | Stock Option (Right to Buy) | D | 8,75 | 41.576 | 41.576 | |||||
| 2020-11-17 | 2020-07-02 | 4 | Howze Yalonda | CDAK | Stock Option (Right to Buy) | D | 15,33 | 166.304 | 166.304 | |||||
| 2020-10-23 | 2020-10-16 | 4 | Alaska Permanent Fund Corp | CDAK | Series C redeemable convertible preferred stock | I | -1.320.097 | 0 | ||||||
| 2020-10-23 | 2020-10-16 | 4 | Alaska Permanent Fund Corp See Footnotes | CDAK | Series C redeemable convertible preferred stock | I | -1.320.097 | 0 | ||||||
| 2020-10-23 | 2020-10-16 | 4 | Alaska Permanent Fund Corp See Footnotes | CDAK | Series B redeemable convertible preferred stock | I | -5.333.333 | 0 | ||||||
| 2020-10-23 | 2020-10-16 | 4 | Alaska Permanent Fund Corp | CDAK | Series B redeemable convertible preferred stock | I | -3.333.333 | 0 | ||||||
| 2020-10-23 | 2020-10-16 | 4 | Alaska Permanent Fund Corp See Footnotes | CDAK | Series A redeemable convertible preferred stock | I | -20.450.000 | 0 | ||||||
| 2020-10-23 | 2020-10-16 | 4 | Alaska Permanent Fund Corp | CDAK | Common Stock | I | 15,0000 | 235.000 | 3.525 | 4.512.895 | ||||
| 2020-10-23 | 2020-10-16 | 4 | Alaska Permanent Fund Corp | CDAK | Common Stock | I | 191.721 | 4.512.895 | ||||||
| 2020-10-23 | 2020-10-16 | 4 | Alaska Permanent Fund Corp | CDAK | Common Stock | I | 191.721 | 4.512.895 | ||||||
| 2020-10-23 | 2020-10-16 | 4 | Alaska Permanent Fund Corp | CDAK | Common Stock | I | 747.321 | 4.512.895 | ||||||
| 2020-10-23 | 2020-10-16 | 4 | Alaska Permanent Fund Corp | CDAK | Common Stock | I | 467.076 | 4.512.895 | ||||||
| 2020-10-23 | 2020-10-16 | 4 | Alaska Permanent Fund Corp | CDAK | Common Stock | I | 2.616.093 | 4.512.895 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | ARCH Venture Fund VIII, L.P. | CDAK | Series C Preferred Stock | I | -1.320.097 | 0 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | ARCH Venture Fund VIII, L.P. | CDAK | Series B Preferred Stock | I | -2.333.333 | 0 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | ARCH Venture Fund VIII, L.P. | CDAK | Series B Preferred Stock | I | -3.000.000 | 0 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | ARCH Venture Fund VIII, L.P. | CDAK | Series A Preferred Stock | I | -6.500.000 | 0 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | ARCH Venture Fund VIII, L.P. | CDAK | Series A Preferred Stock | I | -13.950.000 | 0 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | ARCH Venture Fund VIII, L.P. | CDAK | Common Stock | I | 15,0000 | 235.000 | 3.525 | 2.503.903 | ||||
| 2020-10-20 | 2020-10-16 | 4 | ARCH Venture Fund VIII, L.P. | CDAK | Common Stock | I | 191.721 | 1.350.195 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | ARCH Venture Fund VIII, L.P. | CDAK | Common Stock | I | 326.953 | 1.158.474 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | ARCH Venture Fund VIII, L.P. | CDAK | Common Stock | I | 420.368 | 2.268.903 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | ARCH Venture Fund VIII, L.P. | CDAK | Common Stock | I | 831.521 | 831.521 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | ARCH Venture Fund VIII, L.P. | CDAK | Common Stock | I | 1.784.572 | 1.848.535 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | GILLIS STEVEN See Footnotes | CDAK | Series B Preferred Stock | I | -3.000.000 | 0 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | GILLIS STEVEN See Footnotes | CDAK | Series A Preferred Stock | I | -13.950.000 | 0 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | GILLIS STEVEN See Footnotes | CDAK | Common Stock | I | 15,0000 | 235.000 | 3.525 | 2.503.903 | ||||
| 2020-10-20 | 2020-10-16 | 4 | GILLIS STEVEN See Footnotes | CDAK | Common Stock | I | 420.368 | 2.268.903 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | GILLIS STEVEN See Footnotes | CDAK | Common Stock | I | 1.784.572 | 1.848.535 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | WILLIAMS DOUGLAS E | CDAK | Series C Preferred Stock | D | -66.004 | 0 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | WILLIAMS DOUGLAS E | CDAK | Common Stock | D | 9.585 | 9.585 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | Flagship Ventures Fund V General Partner LLC | CDAK | Series C Preferred Stock | I | -660.048 | 0 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | Flagship Ventures Fund V General Partner LLC | CDAK | Series C Preferred Stock | I | -660.048 | 0 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | Flagship Ventures Fund V General Partner LLC | CDAK | Series B Preferred Stock | I | -2.416.666 | 0 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | Flagship Ventures Fund V General Partner LLC | CDAK | Series B Preferred Stock | I | -2.416.666 | 0 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | Flagship Ventures Fund V General Partner LLC | CDAK | Series A Preferred Stock | I | -4.250.000 | 0 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | Flagship Ventures Fund V General Partner LLC | CDAK | Series A Preferred Stock | I | -4.250.000 | 0 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | Flagship Ventures Fund V General Partner LLC | CDAK | Common Stock | I | 15,0000 | 165.000 | 2.475 | 1.143.177 | ||||
| 2020-10-20 | 2020-10-16 | 4 | Flagship Ventures Fund V General Partner LLC | CDAK | Common Stock | I | 95.861 | 978.177 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | Flagship Ventures Fund V General Partner LLC | CDAK | Common Stock | I | 95.861 | 978.177 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | Flagship Ventures Fund V General Partner LLC | CDAK | Common Stock | I | 338.630 | 882.316 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | Flagship Ventures Fund V General Partner LLC | CDAK | Common Stock | I | 338.630 | 882.316 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | Flagship Ventures Fund V General Partner LLC | CDAK | Common Stock | I | 543.686 | 543.686 | ||||||
| 2020-10-20 | 2020-10-16 | 4 | Flagship Ventures Fund V General Partner LLC | CDAK | Common Stock | I | 543.686 | 543.686 | ||||||
| 2020-10-15 | 2020-10-13 | 4 | Haddock Jason | CDAK | Stock Option (Right to Buy) | D | 15,00 | 10.000 | 10.000 | |||||
| 2020-10-15 | 2020-08-26 | 4 | Haddock Jason | CDAK | Stock Option (Right to Buy) | D | 19,47 | 31.981 | 31.981 | |||||
| 2020-10-15 | 2020-10-13 | 4 | GILLIS STEVEN | CDAK | Stock Option (Right to Buy) | D | 15,00 | 10.000 | 10.000 | |||||
| 2020-10-15 | 2020-10-13 | 4 | Morrison Briggs | CDAK | Stock Option (Right to Buy) | D | 15,00 | 10.000 | 10.000 | |||||
| 2020-10-15 | 2020-10-13 | 4 | LANDER ERIC S | CDAK | Stock Option (Right to Buy) | D | 15,00 | 10.000 | 10.000 | |||||
| 2020-10-15 | 2020-10-13 | 4 | Bernstein Karen | CDAK | Stock Option (Right to Buy) | D | 15,00 | 10.000 | 10.000 | |||||
| 2020-10-15 | 2020-10-13 | 4 | MELAS KYRIAZI THEO | CDAK | Stock Option (Right to Buy) | D | 15,00 | 10.000 | 10.000 | |||||
| 2020-10-15 | 2020-10-13 | 4 | COONEY CHARLES L | CDAK | Stock Option (Right to Buy) | D | 15,00 | 10.000 | 10.000 | |||||
| 2020-10-14 | 3 | Alaska Permanent Fund Corp See footnotes | CDAK | Common Stock, par value $0.0001 per share | I | 63.963 | ||||||||
| 2020-10-13 | 3 | GILLIS STEVEN See Footnotes | CDAK | Common Stock | I | 63.963 | ||||||||
| 2020-10-13 | 3 | LANDER ERIC S By Trust | CDAK | Common Stock | I | 230.267 | ||||||||
| 2020-10-13 | 3 | LANDER ERIC S | CDAK | Common Stock | D | 507.867 | ||||||||
| 2020-10-13 | 3 | AFEYAN NOUBAR | CDAK | Common Stock | I | 485.949 | ||||||||
| 2020-10-13 | 3 | ARCH Venture Partners VIII, L.P. | CDAK | Common Stock | I | 63.963 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
